期刊
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
卷 35, 期 4, 页码 761-773出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2021.03.006
关键词
BTK inhibitors; Toxicity; Side effects; Next-generation BTK inhibitors; CLL; Efficacy; Resistance